Notably, genes like TP53, PTEN, STK11, CDH1, and PALB2, although with varying penetrance, demand inclusion in comprehensive gene panels for identifying individuals susceptible to breast or ovarian cancer. This evidence concerns the gene TP53 and ovarian carcinoma.